NPY1R-targeted peptide-mediated delivery of a dual PPARα/γ agonist to adipocytes enhances adipogenesis and prevents diabetes progression
Stefanie Wittrisch(Leipzig University), Annette G. Beck‐Sickinger(Leipzig University), Karin Mörl(Leipzig University), Nora Klöting(Helmholtz Centre for Environmental Research), Rima Chakaroun(Sahlgrenska University Hospital), Matthias Blüher(Helmholtz Centre for Environmental Research)
Cited by 35
Related Papers
Retinol-Binding Protein 4 and Insulin Resistance in Lean, Obese, and Diabetic Subjects
|New England Journal of Medicine|2006|1.3k
Definition and diagnostic criteria of clinical obesity
|The Lancet Diabetes & Endocrinology|2025|1.3k
Metabolically Healthy Obesity
|Endocrine Reviews|2020|995